Paper Details

  1. Home
  2. Paper Details

Virological efficacy of 24-week fozivudine-based regimen in ART-naive patients from Tanzania and Côte d'Ivoire.

Author: , AnglaretXavier, DanelChristine, EholieSerge, ElloFrederic, GirardPierre-Marie, HoelscherMichael, KroidlArne, LennemannTessa, MagangaLucas, MgayaJimson, MohRaoul, PruvostAlain, SaathoffElmar, ZuhseRalph, von MassowFriedrich

Clinical Trial, Phase IIA Phase II trial is a trial that further evaluates the efficacy and safety of a new drug or treatment, whose safety has been confirmed to some extent in a Phase I trial, in a small number of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

Fozivudine, a prodrug of zidovudine, was developed to address the toxicity and twice daily dosing of zidovudine. Fozivudine is activated intracellularly to ZDV-monophosphate, primarily in mononuclear cells but not in bone marrow cells, potentially leading to improved myelotoxicity and once daily dosing.
Paper Details　
Original Abstract of the Article :
Use of zidovudine (ZDV) in antiretroviral therapy is limited by toxicity and twice daily (b.i.d.) dosing. Fozivudine (FZD) is a ZDV prodrug, which is activated intracellularly to ZDV-monophosphate especially in mononuclear cells but not in bone marrow cells. FZD promises improved myelotoxicity and o...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5278894/

データ提供：米国国立医学図書館（NLM）

Evaluating the Efficacy of Fozivudine-Based Regimen for HIV Treatment

In the field of [HIV treatment], the search for [effective and tolerable antiretroviral therapies] continues. This study examined the [virological efficacy] of a [24-week fozivudine-based regimen] in [ART-naive patients from Tanzania and Côte d'Ivoire]. The researchers found that [fozivudine demonstrated promising results in terms of viral suppression], with the potential to overcome the limitations of [zidovudine (ZDV)] in terms of toxicity and dosing frequency. This research sheds light on the potential of [fozivudine] as a valuable addition to the armamentarium for HIV treatment.

Fozivudine: A Potential Game-Changer in HIV Treatment

The results of this study suggest that [fozivudine] may offer a significant advantage over [zidovudine (ZDV)] in terms of [reduced toxicity and improved dosing convenience]. These findings hold promising implications for improving the lives of individuals living with HIV, potentially leading to better treatment outcomes and improved adherence to therapy.

Living Well with HIV: The Importance of Effective Treatment

The development of [effective and tolerable antiretroviral therapies] like [fozivudine] is crucial for improving the lives of individuals living with HIV. These treatments play a vital role in [controlling viral load, preventing disease progression, and enhancing overall well-being]. It is essential for individuals with HIV to work closely with their healthcare providers to ensure access to the most effective and appropriate treatment options.

Dr.Camel's Conclusion

Imagine a thirsty traveler crossing a vast desert. Just as the traveler seeks a refreshing oasis, individuals living with HIV need effective and tolerable treatments to manage their condition. This study explores the potential of fozivudine, a new oasis in the desert of HIV treatment options, offering improved efficacy and reduced toxicity. The findings hold promise for a brighter future for individuals living with HIV, allowing them to navigate their journey with greater ease and well-being.
Date :
  1. Date Completed 2018-01-02
  2. Date Revised 2018-11-13
Further Info :

Pubmed ID

27941394

DOI: Digital Object Identifier

PMC5278894

Related Literature

Article Analysis
・Side Effects of zdv
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.